Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exposure of Buffalo Milkers to Pathogenic Bacteria and Characterization of Isolated Methicillin-Resistant Staphylococcus spp.
Carraturo F, Alterisio MC, Guccione J, Cerullo V, Salamone M, Morelli M, Libralato G, Russo E, d'Angelo R, Ciaramella P, Di Loria A, Guida M. Carraturo F, et al. Among authors: cerullo v. Int J Environ Res Public Health. 2022 Apr 5;19(7):4353. doi: 10.3390/ijerph19074353. Int J Environ Res Public Health. 2022. PMID: 35410035 Free PMC article.
Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells.
Falanga AP, Greco F, Terracciano M, D'Errico S, Marzano M, Feola S, Sepe V, Fontana F, Piccialli I, Cerullo V, Santos HA, Borbone N. Falanga AP, et al. Among authors: cerullo v. Int J Pharm. 2024 Nov 10;668:124941. doi: 10.1016/j.ijpharm.2024.124941. Online ahead of print. Int J Pharm. 2024. PMID: 39532274 Free article.
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.
Feodoroff M, Hamdan F, Antignani G, Feola S, Fusciello M, Russo S, Chiaro J, Välimäki K, Pellinen T, Branca RM, Lehtiö J, D Alessio F, Bottega P, Stigzelius V, Sandberg J, Clancy J, Partanen J, Malmstedt M, Rannikko A, Pietiäinen V, Grönholm M, Cerullo V. Feodoroff M, et al. Among authors: cerullo v. Oncoimmunology. 2024 Sep 25;13(1):2407532. doi: 10.1080/2162402X.2024.2407532. eCollection 2024. Oncoimmunology. 2024. PMID: 39351443 Free PMC article.
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.
Ferro C, Matos AI, Serpico L, Fontana F, Chiaro J, D'Amico C, Correia A, Koivula R, Kemell M, Gaspar MM, Acúrcio RC, Cerullo V, Santos HA, Florindo HF. Ferro C, et al. Among authors: cerullo v. Adv Healthc Mater. 2024 Aug 29:e2401523. doi: 10.1002/adhm.202401523. Online ahead of print. Adv Healthc Mater. 2024. PMID: 39205539
Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses.
Harjunpää H, Somermäki R, Saldo Rubio G, Fusciello M, Feola S, Faisal I, Nieminen AI, Wang L, Llort Asens M, Zhao H, Eriksson O, Cerullo V, Fagerholm SC. Harjunpää H, et al. Among authors: cerullo v. Oncoimmunology. 2024 Jun 21;13(1):2369373. doi: 10.1080/2162402X.2024.2369373. eCollection 2024. Oncoimmunology. 2024. PMID: 38915784 Free PMC article.
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.
Russo S, Feola S, Feodoroff M, Chiaro J, Antignani G, Fusciello M, D'Alessio F, Hamdan F, Pellinen T, Mölsä R, Tripodi L, Pastore L, Grönholm M, Cerullo V. Russo S, et al. Among authors: cerullo v. Mol Ther Oncol. 2024 Jan 26;32(1):200766. doi: 10.1016/j.omton.2024.200766. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596301 Free PMC article.
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.
Feola S, Hamdan F, Russo S, Chiaro J, Fusciello M, Feodoroff M, Antignani G, D'Alessio F, Mölsä R, Stigzelius V, Bottega P, Pesonen S, Leusen J, Grönholm M, Cerullo V. Feola S, et al. Among authors: cerullo v. J Immunother Cancer. 2024 Mar 8;12(3):e008342. doi: 10.1136/jitc-2023-008342. J Immunother Cancer. 2024. PMID: 38458776 Free PMC article.
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.
Feola S, Chiaro J, Fusciello M, Russo S, Kleino I, Ylösmäki L, Kekäläinen E, Hästbacka J, Pekkarinen PT, Ylösmäki E, Capone S, Folgori A, Raggioli A, Boni C, Tiezzi C, Vecchi A, Gelzo M, Kared H, Nardin A, Fehlings M, Barban V, Ahokas P, Viitala T, Castaldo G, Pastore L, Porter P, Pesonen S, Cerullo V. Feola S, et al. Among authors: cerullo v. Int J Biol Macromol. 2024 Mar;262(Pt 1):129926. doi: 10.1016/j.ijbiomac.2024.129926. Epub 2024 Feb 6. Int J Biol Macromol. 2024. PMID: 38331062
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation.
Falanga AP, Lupia A, Tripodi L, Morgillo CM, Moraca F, Roviello GN, Catalanotti B, Amato J, Pastore L, Cerullo V, D'Errico S, Piccialli G, Oliviero G, Borbone N. Falanga AP, et al. Among authors: cerullo v. Heliyon. 2024 Jan 22;10(3):e24599. doi: 10.1016/j.heliyon.2024.e24599. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38317891 Free PMC article.
136 results